Developer docs
API playgroundTry for free, no card

Search company profiles

RQMIS Inc.

Full company profile

uuid000cqaa

Namestring
RQMIS Inc.
Legal namestring
Regulatory/Quality Management Information Source Incorporated
Websiteurl
rqmis.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

RQMIS Inc. (Regulatory/Quality Management Information Source) is a privately held professional services consulting firm founded in 1996 that provides integrated regulatory, clinical, quality management, postmarket surveillance, and cybersecurity advisory services to manufacturers of medical devices, pharmaceuticals, nutraceuticals, and cosmetics. The firm operates from three offices — Amesbury, MA (US headquarters), Witney, Oxfordshire (UK), and Barcelona, Spain (EU, hosted at the Barcelona Health Hub) — and positions itself as an embedded partner, frequently serving as the fully outsourced regulatory, clinical, and quality function for clients lacking internal teams. Service lines span the full product lifecycle: FDA 510(k)/De Novo/PMA submissions, EU MDR and UKCA marking, clinical study design and management (Phase II/III/IV), quality management system design and compliance (ISO 13485, FDA QSR 21 CFR 820, MDSAP), complaint handling and postmarket surveillance, and FDA administrative support including US Agent and EU/UK Authorized Representation. Notable proprietary assets include 109 Master Investigation Templates covering 15 device families and 330 failure categories, and customized electronic Trial Master File (e-TMF) reference models for medical device studies.

The firm's business model is project-based, quote-driven professional services revenue with no publicly disclosed pricing tiers; engagements are scoped per client. Customer acquisition relies on industry event presence (MEDICA, The Medtech Conference, MTEC Annual Membership Meeting, M2D2 events, 4YFN Barcelona), a 126+ article regulatory blog, published case studies, and partnership referrals through M-Corps/MTEC, M2D2, and the Barcelona and Madrid Health Hubs. The firm competes on the basis of former FDA reviewer talent, 30 years of accumulated regulatory relationships across FDA, EU Notified Bodies, UK MHRA, and Health Canada, and an integrated regulatory+clinical+quality offering that contrasts with competitors operating within single disciplines. Demonstrated outcomes include 510(k) clearance in under six months, combination product clearance in five months, FDA Warning Letter closure in six months, and QMS implementation in 30-45 days. Leadership is concentrated with founder/President Barry Sands; the firm reports 1-10 employees and has no disclosed external funding, M&A activity, or secondary ownership events.

Short descriptiontext

RQMIS Inc. is a Boston-area regulatory, clinical, and quality management consulting firm serving medical device, pharmaceutical, nutraceutical, and cosmetic manufacturers across FDA, EU MDR, and UKCA pathways, with offices in the US, UK, and Spain.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAmesbury, United States
HQ citystring
Amesbury
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device regulatory consulting, FDA submission services, quality management systems, clinical study management, regulatory compliance consulting
Industry4 codes
PRIMARYHLAGAOAD
Regulatory Affairs & Submissions FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAE
Quality Assurance, GxP Compliance & Auditing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAKAM
Training & Competency Programs for GxP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGACAF
Investigator & Site Training / GCP Support
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
Product category
Medical Device Regulatory Consulting
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Regulatory Consulting Services
TypeProfessional Services
Description

Fees for regulatory strategy, submissions (510(k), De Novo, PMA, CE Mark, UKCA), FDA negotiations, Pre-Submission support, US Agent/Authorized Representative services, and Initial Importer services. Revenue is project-based and quote-driven.

rqmis.com
2Clinical Services
TypeProfessional Services
Description

Fees for clinical study design and management, protocol development, IRB submissions, Trial Master File management, clinical monitoring, and post-market clinical follow-up (PMCF) studies. Revenue is project-based and quote-driven.

rqmis.com
3Quality Management Systems (QMS) Services
TypeProfessional Services
Description

Fees for QMS design, implementation, ISO 13485 compliance, FDA QSR (21 CFR 820) alignment, CAPA development, internal audits, and audit readiness support. Revenue is project-based and quote-driven.

rqmis.com
4Postmarket Surveillance and Cybersecurity Services
TypeProfessional Services
Description

Fees for complaint handling, MDR/Vigilance reporting, trend analysis, recall support, and cybersecurity testing/monitoring for medical devices. Revenue is project-based and quote-driven.

rqmis.com
Marketing channels12 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

RQMIS is a professional services consulting firm that helps medical device, pharmaceutical, nutraceutical, and cosmetic manufacturers navigate FDA, EU MDR, UKCA, and Health Canada regulatory pathways. It delivers integrated regulatory strategy and submission services (510(k), De Novo, PMA, CE Mark), clinical study design and management, quality management system design and compliance (ISO 13485, MDSAP, 21 CFR 820), postmarket surveillance and complaint handling, and cybersecurity testing for software-based medical products. Engagements are project-based and quote-driven, with RQMIS frequently acting as a fully outsourced regulatory and quality department for clients lacking internal teams.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • FDA 510(k) clearance achieved in under 6 months (including animal pre-clinical study design and execution)
+5 more records
Product overview1 text field

RQMIS Inc. is a global regulatory consulting firm offering a unified portfolio of regulatory, clinical, and quality services rather than a software product. The core offerings span three principal areas: Regulatory Strategy and Submissions (covering FDA, EU MDR, UKCA pathways), Clinical Study Design and Management (protocol development, IRB submissions, Phase II/III/IV trials), and Quality Systems Design and Compliance (ISO 13485, FDA QSR/QMSR). Supporting services include Postmarket Surveillance, Cybersecurity Testing, FDA Administrative Support, EU/UK Authorized Representation, Initial Importer Services, and Customized Training Programs. The company operates as an embedded consulting partner, providing both strategy and execution support.

Product and service10 records
1Regulatory Services
CategoryRegulatory Consulting
Description

Comprehensive regulatory strategy and submission services covering FDA 510(k), De Novo, PMA, EU MDR, UKCA, Health Canada pathways, combination product clearance, and global market regulatory strategy for medical device, pharmaceutical, nutraceutical, and cosmetic manufacturers.

2Clinical Services
CategoryClinical Consulting
Description

Clinical study design, protocol development, investigational plan creation, IRB submissions, study management, and Phase II/III/IV clinical trial oversight including Trial Master File management, clinical monitoring, and post-market clinical follow-up (PMCF) studies.

3Quality Management Systems (QMS) for Medical Devices
CategoryQuality and Compliance Consulting
Description

Design, implementation, and compliance of quality management systems aligned with ISO 13485, FDA QSR/QMSR (21 CFR 820), and MDSAP requirements, including design controls, risk management, CAPA, document control, internal audits, and audit readiness support.

4Postmarket Surveillance Service (PMSS)
CategoryPostmarket Surveillance
Description

Post-market clinical follow-up (PMCF), complaint handling, MDR/Vigilance reporting, trend analysis, recall management, and postmarket surveillance system design for medical device manufacturers.

5Cybersecurity in Medical Devices
CategoryCybersecurity Consulting
Description

Cybersecurity testing, penetration testing, postmarket surveillance planning, and compliance with FDA cybersecurity guidance requirements for software-based medical products and associated network and cloud-based platforms.

6FDA Administrative Support
CategoryRegulatory Representation Services
Description

FDA correspondence management, facility registration, device listing, US Agent services for foreign manufacturers, and general regulatory administrative support for US market access.

7EU and UK Medical Device Authorized Representation
CategoryRegulatory Representation Services
Description

EU Authorized Representative (EUAR) and UK Responsible Person (UKRP) services for non-EU and non-UK medical device manufacturers seeking market access in the European Union and United Kingdom.

8Initial Importer Service
CategoryRegulatory Representation Services
Description

Designation and ongoing support services for initial importers under FDA regulations, supporting foreign manufacturers bringing products into the US market.

9Customized Training Programs
CategoryRegulatory Training
Description

Specialized training classes in quality and regulatory compliance, including Supplier/Internal Auditing, ISO 13485, Quality Systems Management, 21 CFR 820, and Risk Management ISO 14971, offered to manufacturers and eligible for reimbursement under Massachusetts WTFP.

10Cannabis for Medical Use in the U.S. Regulatory Consulting
CategoryRegulatory Consulting
Description

Regulatory consulting for cannabis-derived medical products including FDA compliance, state-level regulatory navigation, and pathway development for cannabis-based therapeutics in the US market.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1M-Corps (Medical Technology Enterprise Consortium)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-17
Description

RQMIS joined M-Corps, a component of the Medical Technology Enterprise Consortium (MTEC), to provide expert consulting services to MTEC members. M-Corps is an exclusive network of trusted subject matter experts and service providers dedicated to assisting MTEC members with complex business, technical, and regulatory challenges in medical product development.

rqmis.com
Strategic tierMinorTypeOthersAnnounced on2024-07-01
Description

RQMIS partnered with Commonwealth Corporation's Workforce Training Fund Program (WTFP) Express Program to offer specialized training classes in quality and regulatory compliance. Starting July 1, 2025, RQMIS offers 7 approved courses (Supplier/Internal Auditing, ISO 13485, Quality Systems Management, 21 CFR 820, Risk Management ISO 14971) eligible for up to 100% reimbursement for qualifying Massachusetts businesses.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-06-26
Description

RQMIS and Twin Tech Labs announced a partnership to bring cybersecurity testing and monitoring to the software-based medical products market and associated network and cloud-based platforms. Twin Tech Labs contributes decades of experience in IoT, machine learning, and cybersecurity, leveraging open-source components and frameworks to secure digital assets. RQMIS clients have already benefited from guidance and penetration testing by Twin Tech Labs on emergency triage devices and smartphone-based defibrillators.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

RQMIS is a proud sponsor of M2D2 - a lifeline for Massachusetts' smaller medical device companies, offering inventors and executives affordable access to world-class researchers and resources at UMass Lowell and UMass Medical School campuses. RQMIS sponsors the M2D2 IMPACT accelerator program and participates in pitch-off events, providing regulatory expertise to early-stage medical device companies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

RQMIS is a member of Barcelona Health Hub, an innovation hub based at the Recinte Modernista de Sant Pau in Barcelona. The partnership provides visibility within the European health innovation ecosystem and supports RQMIS's growing EU client base.

6Madrid Health Hub
Strategic tierMinorTypeStrategic or Co-development Partner
Description

RQMIS is a member of Madrid Health Hub, providing visibility within the Spanish health innovation ecosystem and supporting the company's EU market presence.

rqmis.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MTEC is a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement with the U.S. Army Medical Research and Development Command (USAMRDC). MTEC's goal is to accelerate development of medical solutions for military personnel and civilians. RQMIS attends MTEC's Annual Membership Meeting and joined M-Corps to provide services to members.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1RCRI
TypeDirect peer
Description

RCRI provides regulatory affairs, clinical research, and quality systems consulting for medical device and combination product companies, closely overlapping RQMIS's core service lines and customer base.

TypeDirect peer
Description

MCRA is a leading medical device-focused regulatory, clinical, and reimbursement consultancy serving the same FDA/EU MDR sponsor base with deeper headcount and orthopedics specialization.

3NAMSA
TypeBroad incumbent
Description

NAMSA is the largest pure-play medical device CRO, offering regulatory, clinical, and laboratory services across the full device lifecycle — a much larger incumbent competing for the same engagements.

TypeDirect peer
Description

MDI Consultants delivers FDA regulatory strategy, 510(k) submissions, and QMS implementation for medical device manufacturers — a directly comparable boutique with similar delivery model.

TypeDirect peer
Description

Greenleaf Health is a Washington, DC-based FDA regulatory and policy consultancy serving pharma, biotech, and medical device companies — directly comparable for FDA-facing strategy work.

TypeDirect peer
Description

The Weinberg Group provides FDA regulatory, quality, and clinical consulting to medical device and combination product companies, mirroring RQMIS's outsourced-function positioning.

TypeDirect peer
Description

StarFish Medical is a medical device design, development, and regulatory services firm serving start-ups through commercial-stage manufacturers — overlapping RQMIS on the medtech regulatory pathway.

TypeBroad incumbent
Description

ICON is a global CRO with extensive device and clinical-trial capabilities and the bench to absorb engagements that overflow boutique consultancies like RQMIS.

TypeEmerging player
Description

Greenlight Guru provides QMS software purpose-built for medical device companies; it competes for the QMS-implementation wallet share that RQMIS is paid to design and deploy.

TypeDirect peer
Description

BioTeknica is a medical device consulting firm offering QMS, regulatory submissions, and compliance services to ISO 13485 / FDA-regulated manufacturers — directly comparable in scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RQMIS Inc.

Medical Device Regulatory Consultingrqmis.com

RQMIS Inc. is a Boston-area regulatory, clinical, and quality management consulting firm serving medical device, pharmaceutical, nutraceutical, and cosmetic manufacturers across FDA, EU MDR, and UKCA pathways, with offices in the US, UK, and Spain.

What RQMIS Inc. does

RQMIS Inc. (Regulatory/Quality Management Information Source) is a privately held professional services consulting firm founded in 1996 that provides integrated regulatory, clinical, quality management, postmarket surveillance, and cybersecurity advisory services to manufacturers of medical devices, pharmaceuticals, nutraceuticals, and cosmetics. The firm operates from three offices — Amesbury, MA (US headquarters), Witney, Oxfordshire (UK), and Barcelona, Spain (EU, hosted at the Barcelona Health Hub) — and positions itself as an embedded partner, frequently serving as the fully outsourced regulatory, clinical, and quality function for clients lacking internal teams. Service lines span the full product lifecycle: FDA 510(k)/De Novo/PMA submissions, EU MDR and UKCA marking, clinical study design and management (Phase II/III/IV), quality management system design and compliance (ISO 13485, FDA QSR 21 CFR 820, MDSAP), complaint handling and postmarket surveillance, and FDA administrative support including US Agent and EU/UK Authorized Representation. Notable proprietary assets include 109 Master Investigation Templates covering 15 device families and 330 failure categories, and customized electronic Trial Master File (e-TMF) reference models for medical device studies.

The firm's business model is project-based, quote-driven professional services revenue with no publicly disclosed pricing tiers; engagements are scoped per client. Customer acquisition relies on industry event presence (MEDICA, The Medtech Conference, MTEC Annual Membership Meeting, M2D2 events, 4YFN Barcelona), a 126+ article regulatory blog, published case studies, and partnership referrals through M-Corps/MTEC, M2D2, and the Barcelona and Madrid Health Hubs. The firm competes on the basis of former FDA reviewer talent, 30 years of accumulated regulatory relationships across FDA, EU Notified Bodies, UK MHRA, and Health Canada, and an integrated regulatory+clinical+quality offering that contrasts with competitors operating within single disciplines. Demonstrated outcomes include 510(k) clearance in under six months, combination product clearance in five months, FDA Warning Letter closure in six months, and QMS implementation in 30-45 days. Leadership is concentrated with founder/President Barry Sands; the firm reports 1-10 employees and has no disclosed external funding, M&A activity, or secondary ownership events.

RQMIS Inc. firmographics

Firmographics
Name
RQMIS Inc.
Legal name
Regulatory/Quality Management Information Source Incorporated
Website
https://rqmis.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
RQMIS Inc. is a Boston-area regulatory, clinical, and quality management consulting firm serving medical device, pharmaceutical, nutraceutical, and cosmetic manufacturers across FDA, EU MDR, and UKCA pathways, with offices in the US, UK, and Spain.
Ownership category
akta.pro rank

RQMIS Inc. industry classification

Industry
Product category
Medical Device Regulatory Consulting
NAICS
Other Scientific and Technical Consulting Services (54169)
akta.pro industry
PRIMARYHLAGAOAD
Regulatory Affairs & Submissions FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAE
Quality Assurance, GxP Compliance & Auditing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAKAM
Training & Competency Programs for GxP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGACAF
Investigator & Site Training / GCP Support

Keywords

  • Medical device regulatory consulting
  • FDA submission services
  • Quality management systems
  • Clinical study management
  • Regulatory compliance consulting

Where RQMIS Inc. is headquartered

Location

Headquarters

HQ city
Amesbury
HQ country
United States
HQ region
North America

Offices3 records

Markets served

RQMIS Inc. business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Regulatory Consulting Services: Fees for regulatory strategy, submissions (510(k), De Novo, PMA, CE Mark, UKCA), FDA negotiations, Pre-Submission support, US Agent/Authorized Representative services, and Initial Importer services. Revenue is project-based and quote-driven.
  2. Clinical Services: Fees for clinical study design and management, protocol development, IRB submissions, Trial Master File management, clinical monitoring, and post-market clinical follow-up (PMCF) studies. Revenue is project-based and quote-driven.
  3. Quality Management Systems (QMS) Services: Fees for QMS design, implementation, ISO 13485 compliance, FDA QSR (21 CFR 820) alignment, CAPA development, internal audits, and audit readiness support. Revenue is project-based and quote-driven.
  4. Postmarket Surveillance and Cybersecurity Services: Fees for complaint handling, MDR/Vigilance reporting, trend analysis, recall support, and cybersecurity testing/monitoring for medical devices. Revenue is project-based and quote-driven.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels12 records

RQMIS Inc. product offering

Product offering

Core offering

RQMIS is a professional services consulting firm that helps medical device, pharmaceutical, nutraceutical, and cosmetic manufacturers navigate FDA, EU MDR, UKCA, and Health Canada regulatory pathways. It delivers integrated regulatory strategy and submission services (510(k), De Novo, PMA, CE Mark), clinical study design and management, quality management system design and compliance (ISO 13485, MDSAP, 21 CFR 820), postmarket surveillance and complaint handling, and cybersecurity testing for software-based medical products. Engagements are project-based and quote-driven, with RQMIS frequently acting as a fully outsourced regulatory and quality department for clients lacking internal teams.

Product overview

RQMIS Inc. is a global regulatory consulting firm offering a unified portfolio of regulatory, clinical, and quality services rather than a software product. The core offerings span three principal areas: Regulatory Strategy and Submissions (covering FDA, EU MDR, UKCA pathways), Clinical Study Design and Management (protocol development, IRB submissions, Phase II/III/IV trials), and Quality Systems Design and Compliance (ISO 13485, FDA QSR/QMSR). Supporting services include Postmarket Surveillance, Cybersecurity Testing, FDA Administrative Support, EU/UK Authorized Representation, Initial Importer Services, and Customized Training Programs. The company operates as an embedded consulting partner, providing both strategy and execution support.

Differentiator

Problem solved

Functional benefit

Products and services

  • Regulatory Services Comprehensive regulatory strategy and submission services covering FDA 510(k), De Novo, PMA, EU MDR, UKCA, Health Canada pathways, combination product clearance, and global market regulatory strategy for medical device, pharmaceutical, nutraceutical, and cosmetic manufacturers.
  • Clinical Services Clinical study design, protocol development, investigational plan creation, IRB submissions, study management, and Phase II/III/IV clinical trial oversight including Trial Master File management, clinical monitoring, and post-market clinical follow-up (PMCF) studies.
  • Quality Management Systems (QMS) for Medical Devices Design, implementation, and compliance of quality management systems aligned with ISO 13485, FDA QSR/QMSR (21 CFR 820), and MDSAP requirements, including design controls, risk management, CAPA, document control, internal audits, and audit readiness support.
  • Postmarket Surveillance Service (PMSS) Post-market clinical follow-up (PMCF), complaint handling, MDR/Vigilance reporting, trend analysis, recall management, and postmarket surveillance system design for medical device manufacturers.
  • Cybersecurity in Medical Devices Cybersecurity testing, penetration testing, postmarket surveillance planning, and compliance with FDA cybersecurity guidance requirements for software-based medical products and associated network and cloud-based platforms.
  • FDA Administrative Support FDA correspondence management, facility registration, device listing, US Agent services for foreign manufacturers, and general regulatory administrative support for US market access.
  • EU and UK Medical Device Authorized Representation EU Authorized Representative (EUAR) and UK Responsible Person (UKRP) services for non-EU and non-UK medical device manufacturers seeking market access in the European Union and United Kingdom.
  • Initial Importer Service Designation and ongoing support services for initial importers under FDA regulations, supporting foreign manufacturers bringing products into the US market.
  • Customized Training Programs Specialized training classes in quality and regulatory compliance, including Supplier/Internal Auditing, ISO 13485, Quality Systems Management, 21 CFR 820, and Risk Management ISO 14971, offered to manufacturers and eligible for reimbursement under Massachusetts WTFP.
  • Cannabis for Medical Use in the U.S. Regulatory Consulting Regulatory consulting for cannabis-derived medical products including FDA compliance, state-level regulatory navigation, and pathway development for cannabis-based therapeutics in the US market.

Quantifiable outcome

  • FDA 510(k) clearance achieved in under 6 months (including animal pre-clinical study design and execution)
  • +5 more outcomes

Companies that use RQMIS Inc.

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

RQMIS Inc. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

RQMIS Inc. partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • M-Corps (Medical Technology Enterprise Consortium)coreStrategic or Co-development Partner · 17 July 2024RQMIS joined M-Corps, a component of the Medical Technology Enterprise Consortium (MTEC), to provide expert consulting services to MTEC members. M-Corps is an exclusive network of trusted subject matter experts and service providers dedicated to assisting MTEC members with complex business, technical, and regulatory challenges in medical product development.
  • Commonwealth Corporation (WTFP)minorOthers · 1 July 2024RQMIS partnered with Commonwealth Corporation's Workforce Training Fund Program (WTFP) Express Program to offer specialized training classes in quality and regulatory compliance. Starting July 1, 2025, RQMIS offers 7 approved courses (Supplier/Internal Auditing, ISO 13485, Quality Systems Management, 21 CFR 820, Risk Management ISO 14971) eligible for up to 100% reimbursement for qualifying Massachusetts businesses.
  • Twin Tech LabscoreTechnology or Integration · 26 June 2023RQMIS and Twin Tech Labs announced a partnership to bring cybersecurity testing and monitoring to the software-based medical products market and associated network and cloud-based platforms. Twin Tech Labs contributes decades of experience in IoT, machine learning, and cybersecurity, leveraging open-source components and frameworks to secure digital assets. RQMIS clients have already benefited from guidance and penetration testing by Twin Tech Labs on emergency triage devices and smartphone-based defibrillators.
  • M2D2 (Medical Device Development Center, UMass Lowell)coreStrategic or Co-development PartnerRQMIS is a proud sponsor of M2D2 - a lifeline for Massachusetts' smaller medical device companies, offering inventors and executives affordable access to world-class researchers and resources at UMass Lowell and UMass Medical School campuses. RQMIS sponsors the M2D2 IMPACT accelerator program and participates in pitch-off events, providing regulatory expertise to early-stage medical device companies.
  • Barcelona Health HubminorStrategic or Co-development PartnerRQMIS is a member of Barcelona Health Hub, an innovation hub based at the Recinte Modernista de Sant Pau in Barcelona. The partnership provides visibility within the European health innovation ecosystem and supports RQMIS's growing EU client base.
  • Madrid Health HubminorStrategic or Co-development PartnerRQMIS is a member of Madrid Health Hub, providing visibility within the Spanish health innovation ecosystem and supporting the company's EU market presence.
  • Medical Technology Enterprise Consortium (MTEC)coreStrategic or Co-development PartnerMTEC is a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement with the U.S. Army Medical Research and Development Command (USAMRDC). MTEC's goal is to accelerate development of medical solutions for military personnel and civilians. RQMIS attends MTEC's Annual Membership Meeting and joined M-Corps to provide services to members.

Scale indicators12 records

Recent moves8 records

Expansion highlights6 records

RQMIS Inc. competitors and assessment

Company assessment

Direct peers

  • RCRI: RCRI provides regulatory affairs, clinical research, and quality systems consulting for medical device and combination product companies, closely overlapping RQMIS's core service lines and customer base.
  • MCRA: MCRA is a leading medical device-focused regulatory, clinical, and reimbursement consultancy serving the same FDA/EU MDR sponsor base with deeper headcount and orthopedics specialization.
  • MDI Consultants: MDI Consultants delivers FDA regulatory strategy, 510(k) submissions, and QMS implementation for medical device manufacturers — a directly comparable boutique with similar delivery model.
  • Greenleaf Health: Greenleaf Health is a Washington, DC-based FDA regulatory and policy consultancy serving pharma, biotech, and medical device companies — directly comparable for FDA-facing strategy work.
  • The Weinberg Group: The Weinberg Group provides FDA regulatory, quality, and clinical consulting to medical device and combination product companies, mirroring RQMIS's outsourced-function positioning.
  • StarFish Medical: StarFish Medical is a medical device design, development, and regulatory services firm serving start-ups through commercial-stage manufacturers — overlapping RQMIS on the medtech regulatory pathway.
  • BioTeknica: BioTeknica is a medical device consulting firm offering QMS, regulatory submissions, and compliance services to ISO 13485 / FDA-regulated manufacturers — directly comparable in scope.

Broad incumbents

  • NAMSA: NAMSA is the largest pure-play medical device CRO, offering regulatory, clinical, and laboratory services across the full device lifecycle — a much larger incumbent competing for the same engagements.
  • ICON plc: ICON is a global CRO with extensive device and clinical-trial capabilities and the bench to absorb engagements that overflow boutique consultancies like RQMIS.

Emerging players

  • Greenlight Guru (MasterControl): Greenlight Guru provides QMS software purpose-built for medical device companies; it competes for the QMS-implementation wallet share that RQMIS is paid to design and deploy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

RQMIS Inc. social profiles

Digital presence

RQMIS Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RQMIS Inc. leadership team

Management profile

Number of profiles

Profiles2 records

RQMIS Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RQMIS Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RQMIS Inc.

What does RQMIS Inc. do?

RQMIS is a professional services consulting firm that helps medical device, pharmaceutical, nutraceutical, and cosmetic manufacturers navigate FDA, EU MDR, UKCA, and Health Canada regulatory pathways. It delivers integrated regulatory strategy and submission services (510(k), De Novo, PMA, CE Mark), clinical study design and management, quality management system design and compliance (ISO 13485, MDSAP, 21 CFR 820), postmarket surveillance and complaint handling, and cybersecurity testing for software-based medical products. Engagements are project-based and quote-driven, with RQMIS frequently acting as a fully outsourced regulatory and quality department for clients lacking internal teams.

Is RQMIS Inc. a public or private company?

RQMIS Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was RQMIS Inc. founded?

RQMIS Inc. was founded in 1996. It employs 11 to 50 people.

Where is RQMIS Inc. based?

RQMIS Inc. is headquartered in Amesbury, United States, in the North America region.

How does RQMIS Inc. make money?

Four revenue lines are on record. Regulatory Consulting Services are the primary driver. The others are clinical Services, quality Management Systems (QMS) Services and postmarket Surveillance and Cybersecurity Services.

Who are RQMIS Inc.'s main competitors?

Direct peers on record are RCRI, MCRA, MDI Consultants, Greenleaf Health, The Weinberg Group, StarFish Medical and BioTeknica. Broad incumbents are NAMSA and ICON plc. Greenlight Guru (MasterControl) is listed as an emerging player.

Does RQMIS Inc. have an API?

No public API is recorded for RQMIS Inc..

What industry is RQMIS Inc. in?

RQMIS Inc.'s product category is Medical Device Regulatory Consulting. Its primary akta.pro industry code is HLAGAOAD, Regulatory Affairs & Submissions FSP, with a secondary code of HLAGAOAE, Quality Assurance, GxP Compliance & Auditing FSP. Its NAICS code is 54169.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales